BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

WuXi Biologics Received First Manufacturing License from Japan

WuXi Biologics (WuXi Bio) , a global company with leading open-access biologics technology platforms, today announced that it has received the Manufacturin...

September 02, 2021 | News

WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate

This additional EMA GMP certificate was issued following a remote inspection conducted by Poland's Chief Pharmaceutical Inspectorate in Apri...

August 03, 2021 | News

CliniRx to offer full suite of Rave EDC and CDM services to sponsors

CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to furt...

July 30, 2021 | News

Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility

Marker Therapeutics, Inc. a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapi...

July 30, 2021 | News

WuXi Biologics Received First GMP manufacturing authorization outside of China

First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system Only 12 months from facility qualific...

July 26, 2021 | News

Vetter Site status now ‘ready for media fill’

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) has further invested in additional capacity to meet this growin...

July 21, 2021 | News

Samsung Biologics and Kineta Announce CDMO Agreement

Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12.1 to IND Samsung Biologics San Francisco R&D cent...

July 21, 2021 | News

Novotech expands virtual clinical trials capabilities

The round was led by two new partners: Dedalus Group a leading healthcare and diagnostic software provider in Europe backed by Ardian, and Novotech H...

July 19, 2021 | News

Lonza Extends Collaboration with Major Biopharmaceutical Partner

Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain for the manufacture of an antibody-drug ...

July 17, 2021 | News

Merck and Universal Agree on the large-scale production of a new pediatric medication.

Merck has entered into a contract manufacturing agreement with Universal Corporation Ltd., Nairobi, Kenya, for the large-scale production of a new pediatri...

July 16, 2021 | News

Bora Group announce the rebranding of Yuta Health to Bora Health

With the name change, Bora plans to complete the merging of the operations of Bora Health and Union Chemical & Pharmaceutical by the end of 2021. In th...

July 06, 2021 | News

Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim

This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesiz...

June 30, 2021 | News

Samsung Biologics continues to leverage remote audits and regulatory inspections

Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessments Recently hosted EMA for 6 PAIs simultaneously using ...

June 24, 2021 | News

Vibalogics to expand cGMP manufacturing capacity for viral vectors

The investment by the CDMO, which specializes in the production of oncolytic viruses, viral vector vaccines and viral vector gene therapy products includes...

June 17, 2021 | News

Stay Connected